Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F11 | P03951 | 1/20 | 0.95 |
| ▸ | LPL | P06858 | 7/20 | 0.58 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.58 |
| ▸ | ABAT | P80404 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.48 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | MGLL | Q99685 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL721501 | 0.97 | F11 (1.00) | F11LPLLIPGABATCA2 | |
| Hydrochloric Acid SCHEMBL21438120 | 0.95 | F11 (0.86) | F11LPLLIPGABATCA2 | |
| SCHEMBL16293873 | 0.87 | F11 (0.73) | F11LPLLIPGABATCA2 | |
| SCHEMBL26085712 | 0.87 | F11 (0.73) | F11LPLLIPGABATCA2 | |
| Phenylboronic Acid SCHEMBL28488393 | 0.83 | F11 (0.68) | F11LPLLIPGCA2CA1 | |
| SCHEMBL17339565 | 0.80 | F11 (0.64) | F11LPLLIPGABATCA2 | |
| SCHEMBL1811673 | 0.80 | F11 (0.64) | F11LPLLIPGCA2CA1 | |
| Hydrochloric Acid SCHEMBL4008745 | 0.78 | F11 (0.68) | F11LPLLIPGCA2CA1 | |
| SCHEMBL13667094 | 0.78 | LPL (0.64) | F11LPLLIPGCA2CA1 | |
| SCHEMBL890400 | 0.78 | LPL (0.73) | F11LPLLIPGCA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 484 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119041053-B | Warm-keeping skin-friendly fabric and preparation method thereof | 深圳歌力思服饰股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119463399-A | Preparation method of heat-conducting polyethylene composite material, flame-retardant dynamic cross-linking agent and preparation method thereof | 横店集团得邦工程塑料有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-116410106-B | Benzamide HBV capsid protein inhibitor and preparation method and application thereof | 山东第二医科大学 | 2024-12-06 | — | — | CN | claimed |
| CN-119041053-A | Warm-keeping skin-friendly fabric and preparation method thereof | 深圳歌力思服饰股份有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-117986571-A | Hyperbranched poly (beta-amino ester) with different groups at tail ends, and preparation method and application thereof | 西安交通大学 | 2024-05-07 | — | — | CN | claimed |
| US-11739115-B2 | Functionalized bile acids for therapeutic and material applications | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2023-08-29 | — | — | US | claimed |
| CN-116410106-A | Benzamide HBV capsid protein inhibitor and preparation method and application thereof | 潍坊医学院 | 2023-07-11 | — | — | CN | claimed |
| CN-114224869-B | Drug-loaded nanoparticle for efficiently delivering siRNA as well as preparation method and application thereof | 湖南省人民医院(湖南师范大学附属第一医院) | 2023-06-23 | — | — | CN | claimed |
| CN-115873246-A | High-temperature-resistant thermosetting supramolecular shape memory polyimide and preparation method thereof | 中国科学院兰州化学物理研究所 | 2023-03-31 | — | — | CN | claimed |
| CN-113929904-B | Functional single-chain cyclic poly (beta-amino ester), preparation method thereof and application of gene delivery drug | 西安交通大学 | 2022-10-25 | — | — | CN | claimed |
| CN-115197053-A | Dihalogen cyclopropane derivative capable of releasing acid and preparation method and application thereof | 中山大学 | 2022-10-18 | — | — | CN | claimed |
| CN-114224869-A | Drug-loaded nanoparticle for efficiently delivering siRNA (small interfering ribonucleic acid), and preparation method and application thereof | 湖南省人民医院(湖南师范大学附属第一医院) | 2022-03-25 | — | — | CN | claimed |
| US-20220024966-A1 | FUNCTIONALIZED BILE ACIDS FOR THERAPEUTIC AND MATERIAL APPLICATIONS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2022-01-27 | — | — | US | claimed |
| CN-113929904-A | Functional single-chain cyclic poly (beta-amino ester), preparation method thereof and application of gene delivery drug | 西安交通大学 | 2022-01-14 | — | — | CN | claimed |
| US-11161870-B2 | Functionalized bile acids for therapeutic and material applications | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-11-02 | — | — | US | claimed |
| CN-112280227-A | PVA plasticizer composition and PVA optical film | 熊烈祥 | 2021-01-29 | — | — | CN | claimed |
| EP-4747301-A2 | HYDROGELS EXHIBITING BORONATE ESTER-MEDIATED DRUG RELEASE | William Marsh Rice University (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026107227-A1 | COMPOSITIONS COMPRISING USP1 INHIBITORS AND METHODS OF USING THE SAME | EIKON THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-1235825-A1 | NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | Pfizer Products Inc. (US) | 2002-09-04 | — | — | EP | disclosed |
| WO-2001040217-A1 | NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | PFIZER PRODUCTS INC. (US) | 2001-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220024966-A1 | FUNCTIONALIZED BILE ACIDS FOR THERAPEUTIC AND MATERIAL APPLICATIONS | NR1H4, SLC10A2, GPBAR1 | F11 2086/4885LPL 825/4885LIPG 712/4885 |
| US-11739115-B2 | Functionalized bile acids for therapeutic and material applications | NR1H4, SLC10A2, GPBAR1 | F11 2086/4885LPL 825/4885LIPG 712/4885 |
| US-11161870-B2 | Functionalized bile acids for therapeutic and material applications | NR1H4, SLC10A2, GPBAR1 | F11 2086/4885LPL 825/4885LIPG 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.